Drug details

Gliadel (polifeprosan 20 with carmustine)

type of Antineoplastics, Alkylating

Gliadel Wafer (carmustine) Implant is a cancer medication used to treat brain tumors, Hodgkin's disease, multiple myeloma, and non-Hodgkin's lymphoma. Gliadel Wafer is sometimes given with other cancer medications.

The drug is often used to treat Multiple myeloma .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• skin redness,
• nausea,
• vomiting,
• fever,
• easy bruising,
• unusual bleeding,
• body aches,
• tiredness,
• dizziness,
• seizure,
• severe headache,
• little or no urination,
• confusion, and
• dry cough or hack,
• unexplained weight loss,
• neck stiffness,
• increased sensitivity to light,
• eye redness,
• pain, burning, swelling, or skin changes where the injection was given,
• clubbing (widening and rounding) of your fingertips or toes,
• sudden vision problems,
• drowsiness
• severe warmth or tingling under the skin,
• slow healing of your incision after Carmustine implant placement,
• shortness of breath (especially with exercise),
• rapid but shallow breathing,

The following drugs are related to Gliadel, either as a replacement or used together:

• CeeNU (lomustine capsules)
• Gleostine (lomustine capsules)
• Pepaxto (melphalan flufenamide for injection for iv use)
• Temodar (temozolomide)